Evidence map›Paper›PMID 24741634›Full record

ArticleJournal of immunology research2014

Unique cytokine signature in the plasma of patients with fibromyalgia.

Jamie Sturgill, Elizabeth McGee, Victoria Menzies

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Evaluating Associations between Average Pain Intensity and Genetic Variation in People with Sickle Cell Disease: An Exploratory Study.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jamie SturgillSchool of Nursing, Virginia Commonwealth University, Richmond, VA 23298, USA ; Institute of Women's Health, Virginia Commonwealth University, Richmond, VA 23298, USA.
Elizabeth McGeeInstitute of Women's Health, Virginia Commonwealth University, Richmond, VA 23298, USA ; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT 05401, USA.
Victoria MenziesSchool of Nursing, Virginia Commonwealth University, Richmond, VA 23298, USA ; Institute of Women's Health, Virginia Commonwealth University, Richmond, VA 23298, USA.
Virginia Commonwealth University · US

Funding

Center of Excellence in Biobehavioral Approaches to Symptom ManagementP30NR011403 · NINR · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRAP, MARY JO · 2009 to 2013
$2.2M
Physical Health, Depressive Symptoms, Happiness, and Maternal CompetenceP20NR008988 · NINR · VIRGINIA COMMONWEALTH UNIVERSITY · PI MCCAIN, NANCY L · 2004 to 2008
$1.5M
NINR NIH HHS P20 NR008988NINR NIH HHS P30 NR011403
6 · The paper itself

Abstract

Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affecting approximately 10 million adults in the United States. The lack of a clear etiology of FMS has limited the effective diagnosis and treatment of this debilitating condition. The objective of this secondary data analysis was to examine plasma cytokine levels in women with FMS using the Bio-Plex Human Cytokine 17-plex Assay. Post hoc analysis of plasma cytokine levels was performed to evaluate patterns that were not specified a priori. Upon examination, patients with FMS exhibited a marked reduction in T(H)2 cytokines such as IL-4, IL-5, and IL-13. The finding of this pattern of altered cytokine milieu not only supports the role of inflammation in FMS but also may lead to more definitive diagnostic tools for clinicians treating FMS. The TH2 suppression provides strong evidence of immune dysregulation in patients with FMS.

Indexed as

AdolescentAdultAgedBlack PeopleFemaleFibromyalgiaHumansInflammationInterleukin-13Interleukin-4Interleukin-5Middle AgedTh1-Th2 BalanceWhite PeopleIL13 protein, humanIL4 protein, humanIL5 protein, humanInterleukin-13Interleukin-4Interleukin-5

Identifiers

PMID24741634
PMCPMC3987983
OpenAlexW2036246029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.